Concepedia
Publication | Open Access
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study
273
Citations
23
References
2017
Year
Page 1